Identification of differentially expressed mRNAs as novel predictive biomarkers for gastric cancer diagnosis and prognosis

Table 1 Associated of glutamic-pyruvic transaminase expression with clinical and pathological features of gastric cancer patients

Clinical and pathological features	n = 70	GPT expression		P value
		Low (35)	High (35)
Gender				0.631
Male	38	18	20
Female	32	17	15
Age (yr)				0.015a
≤ 50	28	9	19
> 50	42	26	16
Lymph node metastasis				0.016a
Yes	51	30	21
No	19	5	14
Pathological staging				0.006b
Sage I-II	25	7	18
Stage III-IV	45	28	17
Distant metastasis				0.001c
Yes	43	28	15
No	27	7	20
Location classification				0.685
Gastric fundus and cardia cancer	31	14	17
Gastric corpus cancer	21	12	9
Gastric antrum cancer	18	9	10

^aP < 0.05.

^bP < 0.01.

^cP < 0.001.

GPT: Glutamic-pyruvic transaminase.